Adducts of l,2-epoxy-3-butene (EB) with haemoglobin were monitored in 17 workers from the 1,3-butadiene (BD) production unit of a petrochemical plant and in nine referents employed at the same factory but not exposed to BD. The air concentrations of BD were determined using stationary and personal monitoring. The ambient level of exposure of the plant workers handling butadiene containers (sampling and voiding) was on average 11.2 ± 18.6 (mean ± SD) mg/m 3 . Maintenance and laboratory workers were exposed to levels ^1.2 mg/m 3 . The particular haemoglobin adduct measured was 2-hydroxy-3-butenylvaline, formed by reaction of N-terminal valine with carbon 1 in EB. The adduct levels were increased (0.16 ± 0.099 pmol/g; n = 10) in plant workers compared with the levels in maintenance and laboratory workers and controls (-0.05 pmol/g; seven laboratory workers and nine controls evaluated). Thus, the method used for adduct determinationderivatization of 200-300 mg globin samples with pentafluorophenyl isothiocyanate according to the A'-alkyl Edman method and detection of the thiohydantoin derivatives by tandem mass spectrometry-is sufficiently sensitive to allow monitoring of exposure to BD down to the p.p.m. level.
Introduction
The increasing interest in studying the carcinogenic and genotoxic properties of 1,3-butadiene (BD) is justified on the basis of its large-scale use in the petrochemical and rubber industries. The worldwide production of BD exceeds 5.5 million tonnes. Styrene-butadiene rubber and latex, and polybutadiene rubber production are the two largest uses of BD (Morrow, 1990) . Occupational exposure to BD can occur during production, storage and transport of the chemical. BD has also been detected in cigarette smoke and automobile exhausts (Brunnemann et al, 1990; Pelz et al, 1990) .
BD is listed in the 1990 Clean Air Act Amendments as one of 189 hazardous air pollutants (US Environmental Protection Agency, 1991) . It is carcinogenic in mice and rats-the mouse being the more susceptible species. IARC has recently classified the compound as a group 2A carcinogen (IARC, 1992) . Methods applicable for biomonitoring human exposure to BD are therefore urgently needed for controlling exposure and eventually for risk assessment.
BD undergoes a complex pathway of metabolic transformation and forms several reactive intermediates. The compound is metabolized by cytochrome P450-dependent monooxygen-ases to the primary reactive metabolite l,2-epoxybutene-3 (EB) (Elfarra et al, 1991) . EB can then be further oxidized to diepoxybutane (DEB) or hydrolysed and oxidized to give a diolepoxide. Csanddy et al. (1992) demonstrated significant quantitative species differences among humans, rats and mice in the in vitro metabolic activation of BD to EB and in the detoxification of EB via epoxide hydrolase and glutathione transferase. They also reported that mouse liver microsomes were capable of forming detectable levels of DEB while this metabolic conversion could not be quantified in rat and human microsomes. The validity of the in vitro species differences were demonstrated in a study by Himmelstein et al. (1994) in which mice and rats were exposed to different concentrations of BD and the concentrations of EB and DEB in blood were measured. The results from these studies show that mice have a 4-8 times higher steady state EB concentration in blood than rats exposed to the same BD concentration. An important finding of these studies was that DEB was detected in the blood of mice but not the blood of rats. EB and DEB are mutagenic in various test systems and show carcinogenic activity in mice and rats (Van Duuren et al, 1963; de Meester, 1988; Autio et al, 1994) . DEB is a bifunctional alkylating agent and is a considerably more effective mutagen than EB (Ehrenberg and Hussain, 1981; Cochrane and Skopek, 1994) .
While blood concentrations of epoxides can be measured in experimental animals following high exposures to BD, this approach to dosimetry is not possible in humans at the low exposure levels that typically occur in BD manufacturing industries. Reaction products (adducts) with haemoglobin or serum albumin in blood can be used to detect and quantify exposure to chemicals that are reactive per se or that are transformed in the body to reactive metabolites (for a review see Skipper and Tannenbaum, 1990) . The analysis of protein adducts is highly sensitive and specific to the chemical, and allows studies at low exposure levels. Studies of blood protein adducts in humans give considerably improved exposure assessments and provide a useful endpoint in epidemiological studies. The dose response for formation of adducts of EB with N-terminal valine in haemoglobin and the stability of the adducts have been investigated in butadiene-exposed mice and rats (Osterman-Golkar et al, 1991 Albrecht et al, 1993) . The haemoglobin adducts are chemically stable. In agreement with the relative blood concentrations found in mice and rats (Himmelstein et al, 1994) , the adduct levels arẽ 3-8 times higher in the former species (Albrecht et al, 1993; Osterman-Golkar et al, 1993) . Because of their chemical stability, EB adducts accumulate during prolonged exposure and reach a steady state level. The steady state level established following prolonged occupational exposure to BD may be used as a proportional measure of the dose received during the 4 months (the life span of erythrocytes in humans) prior to blood sampling (Osterman-Golkar et al, 1976) .
The present study of haemoglobin adducts in BD-exposed workers is a part of an international collaborative project aimed at an assessment of the cancer risk associated with environmental and occupational exposures to BD. Chromosome aberrations, micronuclei and sister chromatid exchanges in peripheral lymphocytes were analysed in the same workers . No exposure related effects were seen in any of these cytogenetic endpoints.
Materials and methods

Study design
The study was performed in a Portuguese petrochemical plant where BD is produced. No previous data exist about the exposure levels on the plant, but since the work is mainly outdoors, low exposure levels were expected. A plant worker group (n = 10), a laboratory and maintenance worker group (n = 7) and a control group (n = 10) were established. The participants in the study were all volunteers. They were asked to complete a questionnaire which solicited information on the following subjects: sex, age, job title, tobacco usage, medications and exposure to chemicals at their workplace. Blood (and urine) samples were collected from all participants after a work shift.
BD exposure concentrations were determined for each plant worker over at least one full shift. For some of the workers, three shifts were monitored over the course of 3 workdays (in-depth surveys). Area samples were collected to determine the BD concentrations in workplace air in the general process area in the vicinity of the distillation columns.
Air sampling and analytical methods
During the in-depth surveys, both personal and area samples were taken. The samples were collected with SKC 222-3 portable low-flow air sampling pumps on coconut-shell charcoal tubes at a flow rate of 50 ml/min. The front section contained 100 mg and the rear section 50 mg of charcoal respectively. The sections were analysed separately and the rear section was used to quantify the breakthrough. The charcoal tubes were connected to the pumps with plastic tubing. Air sample volumes were limited to a maximum of 25 1. The passive sampling was done using 3M 3500 dosimeters. The diffusion rate for BD is 43 ml/min (as stated by the manufacturer). Altogether 27 charcoal tubes and 46 dosimeters were sampled.
The samples were desorbed in acetonitrile and analysed by means of high resolution gas chromatography using an aluminium oxide-fused silica capillary column and flame-ionization detection. Some samples were used for positive identification of BD using mass spectrometry. A detailed description of the sampling and analysis of BD is given elsewhere (Peltonen, 1995) .
In order to ensure the quality of the results, blank samples and quality control spikes were generated, analysed and reported, in accordance with NIOSH quality assurance and quality control procedures (US National Institute for Occupational Safety and Health, 1984) . Field samples were refrigerated during shipment and storage and were found to remain stable for at least 2 weeks when kept at -20°C.
Haemoglobin adduct quantification
Blood sampling and isolation of globin. All blood samples collected were post shift samples. Plasma, 'buffy coat' and erythrocytes were separated using centrifugation (1100 g). The erythrocytes were washed twice with PBS buffer and stored at -20°C. Globin was isolated from the erythrocytes as described by Mowrer et al. (1986) .
Preparation of standards.
A mixture of 2-hydroxy-3-butenylvaline and 1-hydroxymethylallylvaline was prepared by incubation of 1 mmol 14 C-labelled valine (prepared by mixing 1 (iCi L-[U-'
4 C]valine obtained from Amersham, Buckinghamshire, UK, with 1 mmol of L-valine) in 1 ml of 1 M sodium hydroxide with 1.5 mmol EB (purity 98%; Aldrich, Steinheim, Germany). The mixture was left at room temperature for 2 weeks with occasional shaking. A part of the mixture was applied to a Dowex 50Wx4 column (35X2 cm) which was eluted with 1 M hydrochloric acid. Fractions of 10 ml were collected. Valine, 2-hydroxy-3-butenylvaline and l-hydroxymethylallylvaline were eluted after 410, 430 and 500 ml respectively. The 2-hydroxy-3-butenylvaline was re-chromatographed on the Dowex column to remove traces of valine and 1-hydroxymethylallylvaline. The pentafluorophenylthiohydantoin (PFPTH) derivative of 2-hydroxy-3-butenylvaline was prepared according to Tomqvist et al. (1986) and dissolved in toluene. The concentration was determined by means of radioactivity measurements. The purity of the derivative was checked by HPLC. The structural assignment was based on the mass fragmentation pattern of the PFPTH derivative (see Osterman-Golkar etal., 1991) .
A tripeptide (ValGlyGly ethyl ester) containing radiolabelled valine was prepared from valine (7 nCi/mmol) and glycylglycine ethyl ester. A 1 mmol aliquot of L-valine (Sigma, St Louis, MO) was dissolved in 5 ml of water, L-[3,4-146 of 7 |iCi/mmol and the mixture was evaporated to dryness. FMOC (9-fluorenylmethylchloroformate; Fluka Chemie AG, Buchs, Switzerland) was attached to 0.2 mmol of the radiolabelled valine according to Meienhofer et al. (1979) . The crude product was dissolved in dichloromethane and recrystallized by addition of hexane. The valine-FMOC was coupled to glycylglycine ethyl ester hydrochloride (Sigma) by using EDAC [1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride; Bio-Rad, Richmond, CA] according to Sheehan et al. (1965) . The valine-FMOC was dissolved in 1 ml dichloromethane, and 0.2 mmol glycylglycine ethyl ester hydrochloride, 0.2 mmol tnethylamine (Merck, Darmstadt, Germany) and finally 0.22 mmol EDAC was added. The suspension was left to react for 24 h and was then washed successively with water, 0.1 M hydrochloric acid, water, 0.1 M sodium bicarbonate and water. The suspension was evaporated and then kept at -20°C. Uncoupling of FMOC was carried out by suspending the reaction product in dichloromethane containing 20% piperidine (Merck). After 5 min the product was evaporated and dissolved in water and extracted three times with diethyl ether.
The tripeptide, O.I mmol dissolved in water, was reacted with EB (0.2 mmol). After 16 h at room temperature the reaction mixture was extracted several times with toluene to remove excess EB. The adduct content was determined by denvatization as described for globin samples (below) and determination of the radioactivity of the PFPTH derivative.
Denvatization for MS/MS. Globin samples (200-300 mg) from the workers were dissolved in 6 ml of formamide and internal standard globin (3 mg) was added. The internal standard contained 8.75 pmol [ l4 C](2-hydroxypropyl)-valine/mg globin according to radioactivity determinations (Segerback et al., 1992) . The normal background level of hydroxypropylvaline, ~2 pmol/g globin, and the contribution from smoking,-1.6 pmol per 10 cigarettes/day, are low compared with the added amount and were therefore ignored. The samples were derivatized with pentafluorophenyl isothiocyanate (PFPITC; 10 |ll/50 mg globin) according to Tornqvist et al. (1988) and the PFPTH derivatives of the valine adducts were extracted into diethyl ether. The ether was then evaporated and the samples were dissolved in toluene, purified, evaporated to dryness and redissolved in 50 |il of toluene for analysis. Seven samples were reanalysed using as the internal standard a globin containing ( ; injector, VARIAN 1093 SPI (septum-equipped programmable); carrier gas, helium, 8 p.s.i.; reagent gas, argon; collision cell pressure, I mtorr; collision energy, 4 eV; injector temperature programme, 180°C/min from 60 to 320°C, 19 min at 320°C; GC temperature programme, 1 min at 100°C, 20°C/min to 240°C, IO°C/min to 32O°C, 7 min at 320°C. Two-microlitre samples, in toluene, were injected on column. The retention time of the internal standard was ~12 min; the retention times of the two peaks of the PFPTH derivatives of the analyte were 10 and 17 s, respectively, longer. The quantifications were based on measurement of peak areas for the fragment m/z 318, a daughter fragment both of m/z 374 of the analyte and of mJz 362 of the internal standard. The linearity of response was studied by adding various amounts (range 0.01-5 pmol) of the alkylated tripeptide and the internal standard to 200 mg samples of control globin. The peak area of the analyte increased linearly with tripeptide concentration. Assuming that the proportions of adducts with carbons 1 and 2 in EB are equal in the tripeptide and in the human samples, total adduct levels in the human samples may be calculated. In this study we used the response factors of 2-hydroxy-3-butenylvaline-PFPTH for quantification of adducts at carbon 1 of EB. The PFPTH derivative was added to the standard globins containing hydroxypropylvaline-or [ 2 H4]hydroxyethylvaline, and the adducts were determined under the above-mentioned conditions. Thus, the quantifications of adduct levels in samples of the workers are based on the assumption that the derivatization yield of 2-hydroxy-3-butenylvaline-PFPTH is 100%. However, derivatization of similar haemoglobin adducts (hydroxypropylvaline, hydroxyphenethylvaline) under similar reaction conditions show yields of ~80-90%, suggesting that this assumption is reasonable.
Results and discussion
Two different air sampling methods were used in this study. One is based on an active sampling of BD from air utilizing a personal pump and a commercial SKC-221 charcoal tube. The sections of the tube were analysed separately and no breakthrough was detected. The other sample collection tech-nique takes advantage of passive diffusion of BD from air into a charcoal bed (commercial 3M monitors). Both sample types were analysed in the same manner. The charcoal tubes were used to check the passive monitors. The results of the two different sample collection methods showed a good correlation (Figure 1) .
A total of 46 full shift samples (27 personal and 19 area samples) were collected during one survey of the monomer industry (comprising four different sampling days). The BD concentrations detected are presented in Table I . A review of personal exposures by job title suggested that those jobs requiring workers to handle containers of BD present the greatest potential exposure. All the area samples were taken at the location of the plant perimeter. The area samples showed clearly elevated BD concentrations, which were higher than the exposure levels recorded for laboratory workers. This seems to be logical since the laboratory was located ~100-1000 m from emission sources of BD. Laboratory-related emission sources of BD were not detected.
Blood samples from 26 of the 27 subjects were analysed for 2-hydroxy-3-butenylvaline, the product of reaction between carbon 1 of EB and the N-terminal valine in haemoglobin. Analyses of 1-hydroxymethylallylvaline, the product of reaction of carbon 2 of EB, were not attempted. Figure 2a and b shows typical MS/MS ion chromatograms of samples from a control person and a plant worker respectively. There were peaks at the retention times for the EB adducts also in samples from controls, suggesting low-level exposure to BD ( Figure  2a ). These peaks, however, are close to the background noise of the chromatograms and difficult to measure accurately. However, repeated analyses of seven samples covering the 
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whole range of adduct levels gave consistent results (see Materials and methods; R = 0.988). The limit of detection is O.O3-O.O5 pmol/g globin. The adduct levels recorded in laboratory and maintenance workers (mean 0.05 pmol/g globin) were not increased above the background found in controls (mean 0.06 pmol/g globin). Increased adduct levels, on average 0.16 ± 0.099 (mean ± SD) pmol/g globin, were recorded in subjects exposed to BD in the BD production areas (Figures 2b  and 3) . The highest values were found among the non-smokers.
Mainstream smoke contains ~0.06 mg BD/cigarette (range 0.016-0.075 mg BD/cigarette; Brunnemann et al., 1990) . The amount of BD in the mainstream smoke of 30 cigarettes, 1.8 mg, corresponds to the amount (~1.6 mg) which would be inhaled during 8 h of work at an air concentration of 0.1 p.p.m. BD, assuming an alveolar ventilation rate of 0.7 1 kg" 1 min" 1 and a body wt of 70 kg. The smokers reported a cigarette consumption of between 8 and 20 cigarettesAlay (smoking is not allowed in the production area or in the laboratory of the factory). Accordingly, the contribution from smoking to the adduct level in haemoglobin of production plant workers is expected to be smaller than the contribution from exposure to BD (median exposure level ~1 p.p.m.; see Table I ). The adduct levels in smoking and non-smoking laboratory and maintenance workers were similar (~0.05 pmol/g). Among the control subjects, smokers showed somewhat higher values than non-smokers.
Two studies on EB-haemoglobin adducts in occupationally exposed humans have been published previously (OstermanGolkar et al., 1993; van Sittert and van Vliet, 1994) . OstermanGolkar et al. (1993) reported preliminary data on haemoglobin adduct levels in nine workers at a US chemical production plant and a few outside controls. The workers, all non-smokers, were divided into two groups on the basis of work location. Increased adduct levels [1.1-2.6 pmol/g globin; /V-(2-hydroxy-3-butenylvaline + N-(l-hydroxymethylallyl)valine] were found in four workers from BD production areas. Exposures to BD were estimated from an environmental sampling survey which was conducted between 3 and 9 months prior to the collection of blood samples. Time-weighted average (TWA) 8 h area samples showed a mean value of ~3.5 p.p.m., although most samples contained < 1 p.p.m. Most of the samples with higher levels were collected in areas not frequented by workers, suggesting that the average exposure of workers to BD was <3.5 p.p.m. As control groups, five workers from two nonproduction areas-the power plant and the central control area-and two external controls were evaluated. An environmental sampling survey indicated that exposure to BD in the central control area was ~0.03 p.p.m. No data were available on the power plant. Adduct levels in control samples were below the detection limit of 0.5 pmol/g globin. The same paper reports on adduct levels in two heavy cigarette smokers -(2-hydroxy-3-butenyl) valine] in globin from (a) a control subject and (b) a BD-exposed worker. The peak areas correspond to levels <0.1 pmol/g globin in the control and 0.15 pmol/g globin in the exposed subject respectively.
(3=20 cigarettes/day) and two controls. The smokers showed higher adduct levels than the non-smokers. Van Sittert and van Vliet (1994) compared the level of A f -(2-hydroxy-3-butenyl)valine in control and BD-exposed workers at a BD manufacturing site. Control workers were from the same plant but were not involved in BD manufacturing. The median (range) adduct levels were <2 (<l-<4) pmol/g globin in subjects (n = 26) exposed to BD. The BD concentration in personal air samples taken during the study were generally < 1 p.p.m. (8 h TWA). The median concentrations of adducts were <4 (<l-<8) pmol/g globin in control subjects (n = 25). The detection limit in the study of van Sittert and van Vliet, 1-8 pmol/g globin, is thus too high to allow monitoring in workers exposed to < 1 p.p.m. BD. The results are compatible with the low adduct levels found in the present study.
According to studies in experimental animals, the adducts of EB with N-terminal valine in haemoglobin are chemically stable [shown for 2-hydroxy-3-butenylvaline (unpublished data; see also Osterman-Golkar et al., 1991; Recio et ai, 1992) ]. This means that if exposure is long-term, adducts accumulate and a steady state level is reached after 18 weeks (the life span of human erythrocytes) of exposure. This steady (median air concentration for laboratory and maintenance workers) would give 36 p.p.m.h. Thus, the adduct levels recorded for controls are higher than would be expected based on the adduct levels observed in these two worker categories. The origin of this background remains to be clarified. It is possible that the low levels of adducts detected in controls can be associated with occasional visits to plant areas with elevated BD concentrations. If compared at equal BD doses (p.p.m.h), the EB adduct levels observed in BD-exposed workers are considerably lower than those in rats and mice (Osterman-Golkar et al, 1993) . The spread of values within the groups of workers may reflect different exposures, as well as interindividual differences in activation of BD or inactivation of EB.
In conclusion, the method used for adduct determinationderivatization of 200-300 mg globin samples with PFPITC according to the N-alkyl Edman method and detection of the thiohydantoin derivatives by tandem mass spectrometry-is sufficiently sensitive to allow monitoring of exposure to BD at the p.p.m. level or higher. Further studies are required to determine the true background levels and to evaluate the impact of smoking, both as a source of exposure to BD and its possible influence on BD metabolism. Although indicative of an overall low efficiency of BD in humans, a risk estimation would require studies on the relative importance of other reactive BD metabolites.
